[Association of matrix metalloproteinase-2 activity with cell proliferation and growth in ameloblastoma]

Bin Zhang1, Hong-Zhang Huang, Qian Tao

  • 1Department of Oral and Maxillofacial Surgery, The Second Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510120, China.

Abstract

Insights

Matrix metalloproteinase-2 (MMP-2) inhibitor Ro31-9790 did not affect ameloblastoma cell proliferation in vitro. However, it significantly inhibited ameloblastoma tumor growth in vivo, suggesting MMP-2 contributes to tumor progression.

Area of Science:

  • Oral Pathology
  • Oncology
  • Biochemistry

Background:

  • Ameloblastoma is a common odontogenic tumor with a high recurrence rate.
  • Matrix metalloproteinase-2 (MMP-2) is implicated in tumor growth and invasion.
  • Understanding MMP-2's role is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the relationship between MMP-2 activity and ameloblastoma cell proliferation, growth, and invasion.
  • To evaluate the efficacy of an MMP-2 inhibitor, Ro31-9790, on ameloblastoma.
  • To determine if MMP-2 is a viable therapeutic target for ameloblastoma.

Main Methods:

  • Ameloblastoma cells and xenografts were treated with MMP-2 inhibitor Ro31-9790.
  • In vitro studies included MTT assay and flow cytometry to assess cell proliferation and apoptosis.
  • In vivo studies involved subcapsular kidney xenografts, measuring neoplastic volume and histochemistry.

Main Results:

  • Ro31-9790 did not significantly alter ameloblastoma cell proliferation in vitro.
  • No significant changes were observed in cell cycle distribution or apoptosis ratios.
  • Tumor volume and growth were significantly reduced in the Ro31-9790 treatment group compared to controls.

Conclusions:

  • MMP-2 activity is not directly related to ameloblastoma cell proliferation.
  • MMP-2 inhibition effectively suppresses ameloblastoma tumor growth in vivo.
  • MMP-2 may play a role in ameloblastoma growth and invasion, representing a potential therapeutic target.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...